Review: taking Meloxicam and Rituxan together


Summary

Drug interactions are reported among people who take Meloxicam and Rituxan together. This review analyzes the effectiveness and drug interactions between Meloxicam and Rituxan. It is created by eHealthMe based on reports of 145 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Meloxicam and Rituxan >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Meloxicam

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. (latest outcomes from Meloxicam 13,699 users)

Rituxan

Rituxan has active ingredients of rituximab. It is often used in non-hodgkin's lymphoma. (latest outcomes from Rituxan 12,844 users)

On Aug, 27, 2016

145 people who take Meloxicam, Rituxan are studied.


Number of reports submitted per year:

Meloxicam and Rituxan drug interactions.

Drug effectiveness over time:

Meloxicam:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Rituxan:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Meloxicam:
  • female: 50.0% - (1 of 2 people)
  • male: 0.0% - (0 of 0 people)
Rituxan:
  • female: 50.0% - (1 of 2 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Meloxicam:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Rituxan:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • arthralgia
  • drug ineffective
  • weight increased
  • gait disturbance
  • herpes zoster
  • joint swelling
  • oedema peripheral
  • anaemia
  • sinusitis
  • pain
1 - 6 months:
  • abdominal pain upper
  • arthralgia
  • blood cholesterol increased
  • blood triglycerides increased
  • cartilage injury
  • chronic myeloid leukaemia
  • drug ineffective
  • drug intolerance
  • dysgeusia
  • dyspepsia
6 - 12 months:
  • vomiting
  • abdominal pain upper
  • alopecia
  • arthropathy
  • blood cholesterol increased
  • arthralgia
  • malaise
  • drug ineffective
  • immunodeficiency
  • infection
2 - 5 years:
  • breast cancer
  • nasopharyngitis
  • scoliosis
  • viith nerve paralysis
  • weight decreased
not specified:
  • drug ineffective
  • arthralgia
  • pain
  • weight increased
  • joint swelling
  • oedema peripheral
  • nausea
  • gait disturbance
  • malaise
  • pain in extremity

Most common drug interactions by gender *:

female:
  • drug ineffective
  • arthralgia
  • weight increased
  • gait disturbance
  • joint swelling
  • pain
  • oedema peripheral
  • pain in extremity
  • sinusitis
  • blood cholesterol increased
male:
  • arthralgia
  • cough
  • dyspnoea
  • hypertension
  • pleural effusion
  • pneumonia
  • cardiac failure
  • weight decreased
  • bronchopneumonia
  • coronary artery disease

Most common drug interactions by age *:

10-19:
  • pulmonary mycosis
  • serum sickness
20-29:
  • adenocarcinoma
  • adenoma benign
  • adnexa uteri cyst
  • allergic sinusitis
  • anxiety
  • aortic arteriosclerosis
  • aortic calcification
  • aortic valve sclerosis
  • arthralgia
  • arthritis
30-39:
  • neutropenia
  • cold sweat
  • dyspnoea
  • tachycardia
40-49:
  • drug ineffective
  • arthropathy
  • arthritis
  • viral infection
  • nasopharyngitis
  • pain
  • therapeutic response decreased
  • anhedonia
  • anxiety
  • bipolar disorder
50-59:
  • arthralgia
  • gait disturbance
  • joint swelling
  • weight increased
  • febrile neutropenia
  • oedema peripheral
  • abdominal distension
  • dysarthria
  • muscle atrophy
  • nodule
60+:
  • arthralgia
  • drug ineffective
  • weight increased
  • gait disturbance
  • pain in extremity
  • joint swelling
  • oedema peripheral
  • sinusitis
  • blood cholesterol increased
  • blood triglycerides increased

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Meloxicam and Rituxan?

Can you answer these questions?

More questions for: Meloxicam, Rituxan

You may be interested in these reviews

More reviews for: Meloxicam, Rituxan

On eHealthMe, Meloxicam (meloxicam) is often used to treat arthritis. Rituxan (rituximab) is often used to treat non-hodgkin's lymphoma. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.